Why the Immutep (ASX:IMM) share price is on watch today

The Immutep Ltd (ASX: IMM) share price is on watch as the company announced a significant upscale to its manufacturing capacity.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Immutep Ltd (ASX: IMM) share price is on watch this morning on news the company will significantly upscale its manufacturing capacity.

The Immutep share price finished Wednesday's trading session at 43 cents, up 6.1%.

Immutep is a biotech company focused on the development of LAG-3 immunotherapeutic products for cancer and autoimmune diseases.

What did Immutep announce?

In today's release, Immutep advised it will begin ramping up the manufacture its lead product candidate, eftilagimod alpha, otherwise known as efti or IMP321.

The decision to increase production follows the company's positive interim results from its efti clinical trials.

Immutep will expand its efti manufacturing process from 200 litres to a proposed 2,000 litre bioreactor capability. The WuXi Biologics plant in China will house production of the soluble LAG-3 protein, which is expected to scale up throughout 2021.

Although management did not specify the cost involved, it said a recent conversion of warrants will fund the strategic move.

CEO commentary

Commenting on the progress, Immutep CEO Marc Voigt said:

Following the very encouraging interim Overall Survival data announced last week from our largest clinical trial, AIPAC, we have activated our plans to upscale the manufacturing of efti to 2,000L single-use bioreactors to prepare for potential commercial manufacturing and potential registration trials in multiple indications.

WuXi Biologics is an important and long-term partner for us with excellent technical and commercial capabilities. We are entering 2021 in a very strong position, both financially and operationally.

About the Immutep share price

The Immutep share price has soared recently, reaching 63 cents just a few days ago. While its shares have pulled back around 31%, the company is still up 40% from 1 month ago.

Immutep has grown from an ASX micro-cap share to a now small-cap share, with a market capitalisation of $211.9 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Market up or down
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the week...

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Share Gainers

4 ASX 200 shares racing ahead of the benchmark this week

ASX investors sent these four stocks soaring 12% to 18% this week. But why?

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Dateline, DroneShield, Ora Banda, and Pilbara Minerals shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why BHP, Coronado Global, EBR Systems, and Whitehaven Coal shares are pushing higher today

These shares are ending the week on a positive note. Let's find out why.

Read more »

man thinking about whether to invest in bitcoin
Broker Notes

Why Macquarie expects this ASX 200 dividend stock to keep outperforming

Macquarie has tipped this ASX 200 dividend stock to outperform. Let’s find out why.

Read more »

a young woman looks happily at her phone in one hand with a selection of shopping bags in her other hand.
BNPL shares

Up 87% since April, why the Zip share price can keep flying higher into 2026

A leading fund manager expects more outsized gains from Zip shares ahead.

Read more »

Man in mining hat with fists raised and eyes closed looking happy and excited about the Newcrest share price
Share Market News

Why BHP and these ASX dividend stocks are buys

The mining giant and these shares have been named as buys by brokers.

Read more »